Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies (Q67134720)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies |
clinical trial |
Statements
An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II/III Studies (English)
0 references
15 September 2014
0 references
16 August 2025
0 references
2,100
0 references
18 year
0 references